elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37737800-036DFE80-DEFE-4C90-9C49-A4625961D53F
Q37737800-036DFE80-DEFE-4C90-9C49-A4625961D53F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37737800-036DFE80-DEFE-4C90-9C49-A4625961D53F
Posttransplant maintenance therapy in multiple myeloma: the changing landscape.
P2860
Q37737800-036DFE80-DEFE-4C90-9C49-A4625961D53F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37737800-036DFE80-DEFE-4C90-9C49-A4625961D53F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae1a8a3eef4b84d9721c9e16a3adfbb6ca450fec
P2860
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma.